Tag: Pharma Sector In India

AstraZeneca Q4 results: Net profit jumps 128%, revenue rises 34.59%

Posted on May 27, 2024 by filesadmin

AstraZeneca gained approval for a triple combination inhalation therapy for COPD, palivizumab for preventive therapy for respiratory syncytial virus (RSV),

Aurobindo Pharma Q4 results: PAT rises 79.5% to Rs 908 cr, revenue up 14.8%

Posted on May 25, 2024 by filesadmin

2 min read Last Updated : May 25 2024 | 9:51 PM IST Aurobindo Pharma, on Saturday, posted a

Lupin gets USFDA nod to market a generic drug to treat bacterial infections

Posted on March 16, 2024 by filesadmin

Drug maker Lupin on Friday said it has received approval from the US health regulator to market a generic

Lupin receives USFDA approval to market generic hypertension drug

Posted on January 14, 2024 by filesadmin

Drug maker Lupin on Sunday said it has received approval from the US health regulator to market a generic

Aurobindo Pharma’s new injectable facility get 10 observations from US FDA

Posted on December 24, 2023 by filesadmin

Aurobindo Pharma | Photo: Wikipedia Aurobindo Pharma announced on Sunday that the United States Food and Drug Administration (US

Recent Posts